Disclosures: Pai reports serving on the advisory boards of Abbvie and Gilead Sciences.
September 29, 2020
36 min listen
Save

Vaccines for COVID-19

Disclosures: Pai reports serving on the advisory boards of Abbvie and Gilead Sciences.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers and regulatory agencies are racing against the clock to develop a safe and effective vaccine against COVID-19. This episode outlines the path of vaccine development, the top contenders currently in phase 3 trials, as well as questions that remain unanswered.

  • Intro :08
  • The path of vaccine development 2:55
  • Regulatory agencies working on a vaccine 4:09
  • The lifecycle of vaccines 7:43
  • Potential targets of the vaccines 10:58
  • Top contenders in phase 3 trials 14:13
  • Viral vector vaccines 21:03
  • Protein-based vaccines 23:31
  • Approval process 25:46
  • Vaccine safety monitoring 28:23
  • Unanswered questions 31:09
  • Let’s stay tuned for more information 33:12
  • A fairytale analogy to explain vaccine development difficulties 35:10

We’d love to hear from you! Send your comments/questions to Dr. Pai at covid19podcast@healio.com. Be sure to check Healio.com/coronavirus for daily updates on the pandemic and follow us on Twitter @InfectDisNews and @GoHealio.